SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-22-009682
Filing Date
2022-08-24
Accepted
2022-08-24 17:00:52
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1334214
2 GRAPHIC g383770g02w68.jpg GRAPHIC 138643
3 GRAPHIC g383770g11d11.jpg GRAPHIC 132129
4 GRAPHIC g383770g13a00.jpg GRAPHIC 122851
5 GRAPHIC g383770g22b30.jpg GRAPHIC 74160
6 GRAPHIC g383770g22z92.jpg GRAPHIC 112079
7 GRAPHIC g383770g23a23.jpg GRAPHIC 88202
8 GRAPHIC g383770g23s23.jpg GRAPHIC 107760
9 GRAPHIC g383770g24x25.jpg GRAPHIC 78108
10 GRAPHIC g383770g31v63.jpg GRAPHIC 80309
11 GRAPHIC g383770g36n42.jpg GRAPHIC 316344
12 GRAPHIC g383770g80r72.jpg GRAPHIC 178075
13 GRAPHIC g383770g92x08.jpg GRAPHIC 44812
14 GRAPHIC g383770g96o04.jpg GRAPHIC 105570
  Complete submission text file 0000950123-22-009682.txt   3487945
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-06329 | Film No.: 221192166
SIC: 2834 Pharmaceutical Preparations